26843817|t|A UPLC/MS-based metabolomics investigation of the protective effect of ginsenosides Rg1 and Rg2 in mice with Alzheimer's disease.
26843817|a|BACKGROUND: Alzheimer's disease (AD) is a progressive brain disease, for which there is no effective drug therapy at present. Ginsenoside Rg1 (G-Rg1) and G-Rg2 have been reported to alleviate memory deterioration. However, the mechanism of their anti-AD effect has not yet been clearly elucidated. METHODS: Ultra performance liquid chromatography tandem MS (UPLC/MS)-based metabolomics was used to identify metabolites that are differentially expressed in the brains of AD mice with or without ginsenoside treatment. The cognitive function of mice and pathological changes in the brain were also assessed using the Morris water maze (MWM) and immunohistochemistry, respectively. RESULTS: The impaired cognitive function and increased hippocampal Abeta deposition in AD mice were ameliorated by G-Rg1 and G-Rg2. In addition, a total of 11 potential biomarkers that are associated with the metabolism of lysophosphatidylcholines (LPCs), hypoxanthine, and sphingolipids were identified in the brains of AD mice and their levels were partly restored after treatment with G-Rg1 and G-Rg2. G-Rg1 and G-Rg2 treatment influenced the levels of hypoxanthine, dihydrosphingosine, hexadecasphinganine, LPC C 16:0, and LPC C 18:0 in AD mice. Additionally, G-Rg1 treatment also influenced the levels of phytosphingosine, LPC C 13:0, LPC C 15:0, LPC C 18:1, and LPC C 18:3 in AD mice. CONCLUSION: These results indicate that the improvements in cognitive function and morphological changes produced by G-Rg1 and G-Rg2 treatment are caused by regulation of related brain metabolic pathways. This will extend our understanding of the mechanisms involved in the effects of G-Rg1 and G-Rg2 on AD.
26843817	2	6	UPLC	Chemical	-
26843817	71	95	ginsenosides Rg1 and Rg2	Chemical	-
26843817	99	103	mice	Species	10090
26843817	109	128	Alzheimer's disease	Disease	MESH:D000544
26843817	142	161	Alzheimer's disease	Disease	MESH:D000544
26843817	163	165	AD	Disease	MESH:D000544
26843817	184	197	brain disease	Disease	MESH:D001927
26843817	256	271	Ginsenoside Rg1	Chemical	MESH:C035054
26843817	273	278	G-Rg1	Chemical	MESH:C035054
26843817	284	289	G-Rg2	Chemical	-
26843817	322	342	memory deterioration	Disease	MESH:D008569
26843817	381	383	AD	Disease	MESH:D000544
26843817	488	492	UPLC	Chemical	-
26843817	600	602	AD	Disease	MESH:D000544
26843817	603	607	mice	Species	10090
26843817	624	635	ginsenoside	Chemical	MESH:D036145
26843817	673	677	mice	Species	10090
26843817	822	849	impaired cognitive function	Disease	MESH:D003072
26843817	876	881	Abeta	Gene	14961
26843817	896	898	AD	Disease	MESH:D000544
26843817	899	903	mice	Species	10090
26843817	924	929	G-Rg1	Chemical	MESH:C035054
26843817	934	939	G-Rg2	Chemical	-
26843817	1032	1056	lysophosphatidylcholines	Chemical	MESH:D008244
26843817	1058	1062	LPCs	Chemical	MESH:D008244
26843817	1065	1077	hypoxanthine	Chemical	MESH:D019271
26843817	1083	1096	sphingolipids	Chemical	MESH:D013107
26843817	1130	1132	AD	Disease	MESH:D000544
26843817	1133	1137	mice	Species	10090
26843817	1197	1202	G-Rg1	Chemical	MESH:C035054
26843817	1207	1212	G-Rg2	Chemical	-
26843817	1214	1219	G-Rg1	Chemical	MESH:C035054
26843817	1224	1229	G-Rg2	Chemical	-
26843817	1265	1277	hypoxanthine	Chemical	MESH:D019271
26843817	1279	1297	dihydrosphingosine	Chemical	MESH:C005682
26843817	1299	1318	hexadecasphinganine	Chemical	-
26843817	1320	1325	LPC C	Chemical	-
26843817	1336	1341	LPC C	Chemical	-
26843817	1350	1352	AD	Disease	MESH:D000544
26843817	1353	1357	mice	Species	10090
26843817	1373	1378	G-Rg1	Chemical	MESH:C035054
26843817	1419	1435	phytosphingosine	Chemical	MESH:C012491
26843817	1437	1442	LPC C	Chemical	-
26843817	1449	1454	LPC C	Chemical	-
26843817	1461	1466	LPC C	Chemical	-
26843817	1477	1482	LPC C	Chemical	-
26843817	1491	1493	AD	Disease	MESH:D000544
26843817	1494	1498	mice	Species	10090
26843817	1617	1622	G-Rg1	Chemical	MESH:C035054
26843817	1627	1632	G-Rg2	Chemical	-
26843817	1785	1790	G-Rg1	Chemical	MESH:C035054
26843817	1795	1800	G-Rg2	Chemical	-
26843817	1804	1806	AD	Disease	MESH:D000544
26843817	Association	MESH:C012491	MESH:C035054
26843817	Association	MESH:D008244	MESH:D000544
26843817	Association	MESH:C035054	MESH:D013107
26843817	Association	MESH:D019271	MESH:D000544
26843817	Association	MESH:D013107	MESH:D000544
26843817	Negative_Correlation	MESH:C035054	MESH:D000544
26843817	Negative_Correlation	MESH:C035054	MESH:D003072
26843817	Association	MESH:C005682	MESH:C035054
26843817	Negative_Correlation	MESH:C035054	14961
26843817	Positive_Correlation	MESH:D000544	14961
26843817	Association	MESH:C035054	MESH:D008244
26843817	Association	MESH:C035054	MESH:D019271
26843817	Negative_Correlation	MESH:C035054	MESH:D008569

